Premature ejaculation (PE) is the most common male sexual dysfunction, affecting an estimated 20-30% of men across age groups according to population survey data. Despite its prevalence, many men do not discuss it with a physician and do not receive treatment that could substantially improve the condition.

The clinical definition has evolved. The International Society for Sexual Medicine (ISSM) defines PE as: ejaculation that occurs within approximately one minute of vaginal penetration on most sexual encounters, with the inability to delay ejaculation, combined with negative personal consequences (distress, frustration, avoidance). The time criterion (one minute) applies most clearly to lifelong PE; acquired PE (developing after a period of normal ejaculatory control) can involve longer intravaginal ejaculatory latency times (IELTs) that still cause distress.

Lifelong vs. Acquired PE

Lifelong (primary) PE: Present from the first sexual experiences. Strongly associated with genetic factors and neurobiological differences in serotonin signaling. Men with lifelong PE have a familial clustering suggesting hereditary components. Serotonin modulates ejaculatory timing centrally, low serotonin signaling in relevant brain circuits is associated with shorter IELT.

Acquired (secondary) PE: Develops after a period of normal ejaculatory control. More commonly associated with erectile dysfunction (anxiety about losing an erection accelerates ejaculation), thyroid disease, prostatitis, or psychological factors like new relationships or performance anxiety.

Distinguishing lifelong from acquired PE guides treatment, acquired PE often responds to addressing the underlying cause, while lifelong PE typically requires specific PE treatment.

Behavioral Approaches

Start-stop technique (Semans technique): The man or partner stimulates the penis to near ejaculatory inevitability, then stops all stimulation until the urge subsides, then resumes. Repeated practice over weeks builds ejaculatory control. Efficacy in uncontrolled studies is positive; head-to-head comparisons with medication suggest behavioral approaches are less effective as monotherapy than pharmacological treatment but valuable as adjuncts.

Squeeze technique: Similar to start-stop, but instead of cessation of stimulation, the partner squeezes the glans penis firmly until the urge passes. Less commonly used than start-stop in current practice.

Sensate focus and sex therapy: Structured sexual exercises that reduce performance anxiety and improve communication about arousal. Most effective when PE has a significant psychological component.

Pharmacological Treatment: SSRIs

Serotonin reuptake inhibitors (SSRIs) delay ejaculation through their effects on central serotonin signaling. This side effect of SSRIs, typically undesirable in depression treatment, is therapeutic for PE.

Daily SSRI dosing: Paroxetine is the most potent SSRI for ejaculatory delay in head-to-head comparisons. Sertraline, fluoxetine, and clomipramine are also effective. Paroxetine 20-40 mg daily increases IELT by 3-8 times from baseline in clinical trials. Daily dosing requires 1-2 weeks to reach full effect.

On-demand dapoxetine: Dapoxetine is a short-acting SSRI developed specifically for on-demand PE treatment. It reaches peak plasma concentration in approximately 1 hour, with a half-life of 90 minutes, allowing it to be taken 1-3 hours before anticipated sex without the systemic side effects of daily SSRI use. Dapoxetine 30-60 mg produces 2-4 times IELT increase in clinical trials. It is approved in many countries but not yet in the United States.

Topical Anesthetics

Topical lidocaine and prilocaine (EMLA cream) applied to the glans penis 20-30 minutes before sex reduce penile sensitivity. A 2017 Cochrane review confirmed that topical anesthetics are effective for PE. The FDA has approved one combination spray (Promescent-like products) for OTC use.

Concerns include transfer to the partner, which can cause vaginal numbness and reduce partner sensation. Use of a condom after application and before penetration addresses this.

Combination Treatment

For lifelong PE, the most effective approach in clinical practice is combination treatment: a daily or on-demand SSRI combined with behavioral therapy. Behavioral therapy teaches voluntary control skills; the medication reduces the baseline ejaculatory drive that makes voluntary control very difficult. As control improves, the medication dose may be reduced or stopped while behavioral gains persist.

For acquired PE secondary to erectile dysfunction, treating the ED (with a PDE5 inhibitor) often resolves or substantially improves the PE without specific PE treatment. Men anxious about erection maintenance unconsciously rush to ejaculation; removing erection anxiety removes the rushing behavior.

For related men’s health topics, see Erectile Dysfunction: Causes, Risk Factors, and What the Evidence Shows for when ED underlies PE.